📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models. (2022)

First Author: Cheung A

Attributed to: King's College London – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14143361

PubMed Identifier: 35884422

Publication URI: http://europepmc.org/abstract/MED/35884422

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 14

ISSN: 2072-6694